1.F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
Korean Journal of Radiology 2015;16(6):1257-1261
A large number of major cardiovascular events occur in patients due to minimal or some lumen narrowing of the coronary artery. Recent biological studies have shown that the biological composition or vulnerability of the plaque is more critical for plaque rupture compared to the degree of stenosis. To overcome the limitations of anatomical images, molecular imaging techniques have been suggested as promising imaging tools in various fields. F-18 fluorodeoxyglucose (FDG), which is widely used in the field of oncology, is an example of molecular probes used in atherosclerotic plaque evaluation. FDG is a marker of plaque macrophage glucose utilization and inflammation, which is a prominent characteristic of vulnerable plaque. Recently, F-18 fluoride has been used to visualize vulnerable plaque in clinical studies. F-18 fluoride accumulates in regions of active microcalcification, which is normally observed during the early stages of plaque formation. More studies are warranted on the accumulation of F-18 fluoride and plaque formation/vulnerability; however, due to high specific accumulation, low background activity, and easy accessibility, F-18 fluoride is emerging as a promising non-invasive imaging probe to detect vulnerable plaque.
Atherosclerosis/pathology/*radiography
;
Coronary Vessels
;
Fluorodeoxyglucose F18/chemistry
;
Humans
;
Plaque, Atherosclerotic
;
*Positron-Emission Tomography
;
*Tomography, X-Ray Computed
2.Significance of Microalbuminuria in Relation to Subclinical Coronary Atherosclerosis in Asymptomatic Nonhypertensive, Nondiabetic Subjects.
Hyo Eun PARK ; Nam Ju HEO ; Minkyung KIM ; Su Yeon CHOI
Journal of Korean Medical Science 2013;28(3):409-414
We aimed to investigate the significance of microalbuminuria and its relationship with subclinical atherosclerosis in nonhypertensive and nondiabetic patients, by using coronary artery computed tomography (CT). A total of 1,318 nonhypertensive and nondiabetic subjects who had taken coronary artery CT and measured spot urine albumin to creatinine ratio (UACR) were evaluated. The atherosclerotic changes of coronary arteries were greater in subjects with microalbuminuria, reflected by coronary artery calcium score (CACS) and significant coronary artery stenosis (CACS > or = 100 in 15.3% vs 7.6% and stenosis > or = 50% in 11.5% vs 4.9% of patients with vs without microalbuminuria, P = 0.008 and P = 0.011, respectively). Among various parameters that are known as a risk factor or possible biomarkers of coronary artery disease, presence of microalbuminuria, age and Framingham risk score were significantly related to coronary artery stenosis. Among them the presence of microalbuminuria showed stronger correlation than others to the coronary artery stenosis detected by CT, even after adjusting confounding factors (OR 3.397, 95% confidence interval 1.138 to 10.140, P = 0.028). The presence of microalbuminuria by UACR was significantly associated with presence of coronary artery stenosis > or = 50% in asymptomatic, nonhypertensive and nondiabetic general population. Our study suggests that the presence of microalbuminuria may imply subclinical coronary artery disease, even in asymptomatic population.
Adult
;
Age Factors
;
Aged
;
Albuminuria/*complications
;
Blood Pressure
;
Calcium/analysis
;
Coronary Artery Disease/complications/*radiography
;
Coronary Stenosis/complications
;
Coronary Vessels/chemistry
;
Creatinine/urine
;
Female
;
Humans
;
Male
;
Middle Aged
;
Odds Ratio
;
Retrospective Studies
;
Risk Factors
;
Sex Factors
;
Tomography, X-Ray Computed
3.Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score.
Mi Hae SEO ; Eun Jung RHEE ; Se Eun PARK ; Cheol Young PARK ; Ki Won OH ; Sung Woo PARK ; Won Young LEE
The Korean Journal of Internal Medicine 2015;30(1):73-81
BACKGROUND/AIMS: The aim was to determine which of three sets of metabolic syndrome (MetS) criteria (International Diabetes Federation [IDF], National Cholesterol Education Program Adult Treatment Panel III [ATP III], and European Group for the Study of Insulin Resistance [EGIR]) best predicts the coronary artery calcification (CAC) score in a cross-sectional study. This has not been evaluated in previous studies. METHODS: A total of 24,060 subjects were screened for CAC by multi-detector computed tomography. The presence of CAC was defined as a CAC score > 0. The odds ratio for the presence of CAC was analyzed for three different sets of MetS criteria and according to number of MetS components. RESULTS: CAC was observed in 12.6% (3,037) of the subjects. Patients with MetS, as defined by the IDF, ATP III, and EGIR criteria, had a CAC rate of 23.0%, 25.1%, and 29.5%, respectively (p < 0.001). Comparisons of C statistics for multivariate regression models revealed no significant difference among the three sets of criteria. After adjustment for risk factors, the ATP III criteria produced a slightly higher odds ratio for CAC compared with the other criteria, but this difference was not significant. The risk factor-adjusted odds ratio for the presence of CAC increased from 1 to 1.679 as the number of MetS components defined by ATP III increased from 0 to > or = 3 (p for trend < 0.001). CONCLUSIONS: The presence of MetS was associated with the presence of CAC. There was no significant difference among the three sets of MetS criteria in terms of the ability to predict CAC. An increase in the number of MetS components was associated with an increased odds of CAC.
Adult
;
Asymptomatic Diseases
;
Biological Markers/blood
;
Calcium/*analysis
;
Coronary Angiography/methods
;
Coronary Artery Disease/blood/*epidemiology/radiography
;
Coronary Vessels/*chemistry/radiography
;
Cross-Sectional Studies
;
Female
;
Humans
;
Male
;
Metabolic Syndrome X/blood/diagnosis/*epidemiology
;
Middle Aged
;
Multidetector Computed Tomography
;
Multivariate Analysis
;
Odds Ratio
;
Predictive Value of Tests
;
Prevalence
;
Republic of Korea/epidemiology
;
Risk Assessment
;
Risk Factors
;
Vascular Calcification/blood/*epidemiology/metabolism/radiography